- Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF. Prognostic nutritional index
in gastrointestinal surgery. Am J Surg. 1980 Jan;139(1):160-7.
Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery
of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984 Sep;85(9):1001-5.Okada S, Shimada J, Kato D, Tsunezuka H, Teramukai S, Inoue M. Clinical Significance
of Prognostic Nutritional Index After Surgical Treatment in Lung Cancer. Ann Thorac
Surg. 2017 Jul;104(1):296-302.Miao Y, Li S, Yan Q, Li B, Feng Y. Prognostic Significance of Preoperative Prognostic
Nutritional Index in Epithelial Ovarian Cancer Patients Treated with Platinum-Based
Chemotherapy. Oncol Res Treat. 2016;39(11):712-719.Haraga J, Nakamura K, Omichi C, Nishida T, Haruma T, Kusumoto T, et al. Pretreatment
prognostic nutritional index is a significant predictor of prognosis in patients with
cervical cancer treated with concurrent chemoradiotherapy. Mol Clin Oncol. 2016 Nov;5(5):567-574.Han WX, Chen ZM, Wei ZJ, Xu AM. Preoperative pre-albumin predicts prognosis of patients
after gastrectomy for adenocarcinoma of esophagogastric junction. World J Surg Oncol.
2016 Nov 3;14(1):279.Yang Y, Gao P, Chen X, Song Y, Shi J, Zhao J, et al. Prognostic significance of preoperative
prognostic nutritional index in colorectal cancer: results from a retrospective cohort
study and a meta-analysis. Oncotarget. 2016 Sep 6;7(36):58543-58552.Ke M, Xu T, Li N, Ren Y, Shi A, Lv Y, et al. Prognostic nutritional index predicts
short-term outcomes after liver resection for hepatocellular carcinoma within the
Milan criteria. Oncotarget. 2016 Dec 6;7(49):81611-81620.Chan AW, Chan SL, Wong GL, Wong VW, Chong CC, Lai PB, et al. Prognostic Nutritional
Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma
After Surgical Resection. Ann Surg Oncol. 2015 Dec;22(13):4138-48.He CB, Lin XJ. Inflammation scores predict the survival of patients with hepatocellular
carcinoma who were treated with transarterial chemoembolization and recombinant human
type-5 adenovirus H101. PLoS One. 2017 Mar 29;12(3):e0174769Taussig MD, Irene Koran ME, Mouli SK, Ahmad A, Geevarghese S, Baker JC, et al. Neutrophil
to lymphocyte ratio predicts disease progression following intra-arterial therapy
of hepatocellular carcinoma. HPB (Oxford). 2017 May;19(5):458-464.Shirabe K, Mano Y, Muto J, Matono R, Motomura T, Toshima T, et al. Role of tumor-associated
macrophages in the progression of hepatocellular carcinoma. Surg Today. 2012;42:1–7.Harimoto N, Shirabe K, Nakagawara H, Toshima T, Yamashita Y, Ikegami T, et al. Prognostic
factors affecting survival at recurrence of hepatocellular carcinoma after living-donor
liver transplantation: with special reference to neutrophil/lymphocyte ratio. Transplantation.
2013;96:1008–12.Peng W, Li C, Wen TF, Yan LN, Li B, Wang WT, et al. Neutrophil to lymphocyte ratio
changes predict small hepatocellular carcinoma survival. J Surg Res. 2014;192:402–8.Ke M, Xu T, Li N, Ren Y, Shi A, Lv Y, et al. Prognostic nutritional index predicts
short-term outcomes after liver resection for hepatocellular carcinoma within the
Milan criteria. Oncotarget. 2016 Dec 6;7(49):81611-81620.Koike Y, Miki C, Okugawa Y, Yokoe T, Toiyama Y, Tanaka K, et al. Preoperative C-reactive
protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol.
2008;98:540–544.Okabayashi T, Nishimori I, Sugimoto T, Maeda H, Dabanaka K, Onishi S, et al. Effects
of branched-chain amino acids-enriched nutrient support for patients undergoing liver
resection for hepatocellular carcinoma. J Gastroenterol Hepatol. 2008;23:1869–1873.Okabayashi T, Nishimori I, Nishioka A, Yamashita K, Sugimoto T, Dabanaka K, et al.
Long-term effects of multimodal treatment for patients with resectable carcinoma of
the pancreas. Oncol Rep. 2008;20:651–656.